Evren Technologies

Advancing PTSD Treatment with an FDA Breakthrough Device
Overview
Raised: $252,618
Rolling Commitments ($USD)
09/04/2022
$1,599
118
2018
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$0 |
$-418,616 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$0 |
$13,388 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$0 |
$116,875 |
Short-Term Debt |
$0 |
$134,232 |
Long-Term Debt |
$0 |
$514,900 |
Total Liabilities |
$0 |
$649,132 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual